- Report
- September 2026
- 196 Pages
Global
From €3277EUR$3,545USD£2,731GBP
€3641EUR$3,939USD£3,035GBP
- Report
- September 2026
- 191 Pages
Global
From €3277EUR$3,545USD£2,731GBP
€3641EUR$3,939USD£3,035GBP
- Report
- September 2026
- 185 Pages
Global
From €3277EUR$3,545USD£2,731GBP
€3641EUR$3,939USD£3,035GBP
- Report
- September 2026
- 187 Pages
Global
From €3277EUR$3,545USD£2,731GBP
€3641EUR$3,939USD£3,035GBP
- Report
- November 2026
- 372 Pages
Global
From €5407EUR$5,850USD£4,507GBP
- Report
- November 2026
- 273 Pages
Global
From €5407EUR$5,850USD£4,507GBP
- Report
- November 2026
- 183 Pages
Global
From €5407EUR$5,850USD£4,507GBP
- Report
- November 2026
- 474 Pages
Global
From €5407EUR$5,850USD£4,507GBP
- Report
- November 2026
- 231 Pages
Global
From €5407EUR$5,850USD£4,507GBP
- Report
- November 2026
- 302 Pages
Global
From €5407EUR$5,850USD£4,507GBP
- Report
- November 2026
- 439 Pages
Global
From €5407EUR$5,850USD£4,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4150EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4150EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4150EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4150EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4150EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4150EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4150EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4150EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4150EUR$4,490USD£3,460GBP

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs.
Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more